$179.95
+0 (+0%)
At Close: Jun 23, 2026
Here's Why You Should Retain Masimo (MASI) Stock for Now
02:35pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Here's Why You Should Retain Masimo (MASI) Stock for Now
11:18am, Tuesday, 17'th Jan 2023
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Masimo CEO on how its watch compares to the Apple Watch
07:34pm, Wednesday, 11'th Jan 2023
Cramer spoke with Masimo Corporation CEO Joe Kiani on Wednesday.
Masimo (MASI) Gets Favorable Ruling in Apple Watch Patent Suit
02:01pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
A U.S. Administrative Law Judge ruled that Apple watches infringe one of Masimo's (MASI) pulse oximeter patents. An import ban may follow for Apple watches.
The Latest Analyst Ratings for Masimo
02:00pm, Wednesday, 11'th Jan 2023 Benzinga
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
0
1
0
0
Last 30D
1
0
0
UnitedHealth's (UNH) UnitedHealthcare Unit to Aid Q4 Earnings?
01:43pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
An increase in the number of people served in the commercial domestic business of UnitedHealth's (UNH) UnitedHealthcare segment is likely to boost fourth-quarter results.
How Masimo Is Taking On Electronics Giant Apple — And Winning
10:16am, Wednesday, 11'th Jan 2023
Masimo stock surged Wednesday after a U.S. judge ruled Apple infringed on two patents protecting Masimo's blood-oxygen-reading technology. The post How Masimo Is Taking On Electronics Giant Apple —
U.S. judge rules Apple Watches infringed Masimo patent - medical device maker
08:56pm, Tuesday, 10'th Jan 2023
A U.S. judge ruled that Apple had infringed on one of Masimo Corp's pulse oximeter patents by importing and selling certain Apple Watches with light-based pulse oximetry functionality and components,
UnitedHealth (UNH) to Post Q4 Earnings: What You Should Know
02:41pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
UnitedHealth Group's (UNH) fourth-quarter results are likely to reflect growing premiums, products and higher expenses.
Masimo's (MASI) SpHb During Elective CS Favored by New Study
06:28pm, Wednesday, 04'th Jan 2023 Zacks Investment Research
Masimo's (MASI) SpHb is likely to indicate clinically acceptable accuracy of Hb measurement even at low Hb levels in patients undergoing CS with antepartum hemorrhage.
Masimo to Present in 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 04'th Jan 2023
IRVINE, Calif.--( BUSINESS WIRE )--Masimo (NASDAQ: MASI) today announced that its management will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:
Masimo's (MASI) SpHb During Elective CS Favored by New Study
03:03pm, Wednesday, 04'th Jan 2023
Masimo's (MASI) SpHb is likely to indicate clinically acceptable accuracy of Hb measurement even at low Hb levels in patients undergoing CS with antepartum hemorrhage.
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
12:25pm, Tuesday, 20'th Dec 2022 Benzinga
Although US stocks closed lower on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
03:02pm, Thursday, 15'th Dec 2022 Benzinga
Upgrades
B of A Securities upgraded the previous rating for Radian Group Inc (NYSE:RDN) from Neutral to Buy. Radian Group earned $1.31 in the third quarter, compared to $0.67 in the year-ago quarter.
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
01:33pm, Friday, 09'th Dec 2022 Zacks Investment Research
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
Sign In
Buy MASI